HOME > ACADEMIC EVENTS > Content

The First Affiliated Hospital of ZZU Makes a breakthrough in the Field of Genetic Mechanism of Natural Killer T-cell Lymphoma

Publisher:   From:   Publish Date:2019-12-30   Read Count:

The First Affiliated Hospital of ZZU Makes a breakthrough in the Field of Genetic Mechanism of Natural Killer T-cell Lymphoma

Recently, the research team of Prof. Zhang Mingzhi and Prof. Li Wencai from the First Affiliated Hospital of ZZU made a breakthrough in the field of genetic mechanism of natural killer T-cell lymphoma (NKTCL), revealing the new mechanism of NKTCL. Relevant research results were published online in Nature Communications, a sub-Journal of Nature, in the form of academic papers. Dr. Li Zhaoming and Dr. Zhang Xudong from the oncology department of the First Affiliated Hospital were co-authors of this paper, and Prof. Zhang Mingzhi and Prof. Li Wencai were co-corresponding authors.


PREV:Zhang Mingzhi’s team from First Affiliated Hospital of Zhengzhou University studied the creation of chemotherapy regimen which was included in the 2020 edition of the NCCN
NEXT:Prof. Zhang Jinying, First Affiliated Hospital of ZZU, Makes a Breakthrough in the Research of the Pathogenesis of Atherosclerosis

郑州大学医学院官方微信
扫一扫在手机打开当前页
郑州大学官方微信

Address:40 North Road, 27 District University, Zhengzhou  ZIP code:450052    Tel:0371-66658007/66658829    Email:yxyzhb@zzu.edu.cn 
   Copyright @2019 Zhengzhou University School of Medicine All Right Reserved

Page View: